These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3834071)

  • 41. Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans.
    Knights KM; McLean CF; Tonkin AL; Miners JO
    Br J Clin Pharmacol; 1995 Aug; 40(2):153-6. PubMed ID: 8562298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.
    Miners JO; Robson RA; Birkett DJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):240-3. PubMed ID: 6487463
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemostasis profile in women taking low-dose oral contraceptives.
    David JL; Gaspard UJ; Gillain D; Raskinet R; Lepot MR
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):420-3. PubMed ID: 2142579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
    van Kammen E; Thijssen JH; Rademaker B; Schwarz F
    Contraception; 1975 Jan; 11(1):53-9. PubMed ID: 1116360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.
    Wagner JG; Wexler D; Ağabeyoğlu IT; Bergstrom RF; Sakmar E; Kay DR
    J Lab Clin Med; 1981 Apr; 97(4):487-501. PubMed ID: 7205057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of ampicillin on oral contraceptive steroids in women.
    Back DJ; Breckenridge AM; MacIver M; Orme M; Rowe PH; Staiger C; Thomas E; Tjia J
    Br J Clin Pharmacol; 1982 Jul; 14(1):43-8. PubMed ID: 6809025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinyloestradiol.
    Rogers SM; Back DJ; Stevenson PJ; Grimmer SF; Orme ML
    Br J Clin Pharmacol; 1987 Jun; 23(6):721-5. PubMed ID: 3111513
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The nonlinear pharmacokinetics of prednisone and prednisolone. II. Plasma protein binding of prednisone and prednisolone in rabbit and human plasma.
    Ferry JJ; Wagner JG
    Biopharm Drug Dispos; 1987; 8(3):261-72. PubMed ID: 3593903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF; Benet LZ
    Clin Pharmacol Ther; 1986 Apr; 39(4):425-9. PubMed ID: 3956058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Fruzzetti F; Ricci C; Fioretti P
    Contraception; 1994 Jun; 49(6):579-92. PubMed ID: 8070263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma levels of ethinylestradiol (EE) during cyclic treatment with combined oral contraceptives.
    Kaufman JM; Thiery M; Vermeulen A
    Contraception; 1981 Nov; 24(5):589-602. PubMed ID: 7318439
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of contraceptive steroids with binding proteins and the clinical implications.
    Fotherby K
    Ann N Y Acad Sci; 1988; 538():313-20. PubMed ID: 3056193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
    Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
    Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune reactivity of women on hormonal contraceptives. Phytohemagglutinin and concanavalin-A induced lymphocyte response.
    Gerretsen G; Kremer J; Bleumink E; Nater JP; de Gast GC; The TH
    Contraception; 1980 Jul; 22(1):25-9. PubMed ID: 7418405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.
    Jespersen J; Petersen KR; Skouby SO
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):396-403. PubMed ID: 2196812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic changes during treatment with two different progestogens.
    Refn H; Kjaer A; Lebech AM; Borggaard B; Schierup L; Bremmelgaard A
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose dependent pharmacokinetics of prednisone and prednisolone in man.
    Rose JQ; Yurchak AM; Jusko WJ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):389-417. PubMed ID: 7310640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical aspects of the relationship between oral contraceptives and abnormalities of the hemostatic system: relation to the development of cardiovascular disease.
    Kelleher CC
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):392-5. PubMed ID: 2196811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.